KromaTiD
PrivateLast Round
Series C
Aug 20, 2025
Total Funding Raised
$14.21M
Company Overview
KromaTiD operates in Healthcare & Life Sciences and is based in Boulder, Colorado. Its latest recorded funding round was a Series C round in August 2025.
KromaTiD is a biotechnology company that provides proprietary single-cell genomic structural analysis products and services to support cell and gene therapy development.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
KromaTiD Comparables
Compare KromaTiD with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Bionano Genomics Inc | 79% | |
| Creative Biolabs | 76% | |
| MaxCyte Inc | 71% |
For institutional investors. Book with your work email.
KromaTiD Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Aug 20, 2025 | ||||
| Corporate Funding | Apr 21, 2021 | ||||
| Series A | Aug 13, 2019 | ||||
| Grant | Jun 10, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
KromaTiD Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant |
| First Capital Ventures | Series A |
| BroadOak Capital Partners | Series C, Corporate Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 17, 2026
Monthly visitors increased 108% MoM, reaching 2.8K.
- Aug 20, 2025
$8M round led by BroadOak Capital Partners.
For institutional investors. Book with your work email.
KromaTiD Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about KromaTiD's valuation, stock price, and market status.
Is KromaTiD a public or private company?
KromaTiD is a private company.
What is the current stock price of KromaTiD?
KromaTiD is a private company, so its shares have no public market price. Caplight tracks KromaTiD's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is KromaTiD worth (valuation)?
Valuation information for KromaTiD is not publicly available.
Can I buy KromaTiD stock?
KromaTiD shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was KromaTiD's last funding round?
KromaTiD's most recent funding round was Series C on August 20, 2025.
Who are the main investors in KromaTiD?
Key investors in KromaTiD include First Capital Ventures, BroadOak Capital Partners.
Will KromaTiD IPO soon?
No public IPO plans have been announced for KromaTiD.
How can I track KromaTiD secondary market activity?
Caplight tracks bids, offers, and trades in KromaTiD's shares on secondary markets.